Investing Profile

Nina Kjellson

VCInvestor

General Partner at Canaan Partners

canaan.com/team/nina-kjellsonMenlo Park, California
Photo of Nina Kjellson, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
22
$800M
CompanyStageDateRound SizeTotal Raised
Vineti
Series COct 2020$33M
Series BApr 2018$33.5M
$66.5M
Dauntless Pharmaceuticals
Series AFeb 2017$25M
$25M
Tizona Therapeutics
Series BMar 2016$43M
$43M
Welltok
Series DJan 2015$37M
Series CFeb 2014$22.1M
Series BApr 2013$18.7M
$116.5M
Co-investors: Kevin Spain (Emergence Capital), Blake Wu (New Enterprise Associates (NEA)), Sharon Stevenson (Okapi Venture Capital)
Cidara Therapeutics
Series AJun 2014$32M
$32M
Ocera Therapeutics
Post-IPO EquityNov 2013$28M
$28M
Labrys Biologics
Series AJan 2013$31M
Venture RoundDec 2012$14.6M
$45.6M
Co-investors: Wende Hutton (Canaan Partners)
Cebix
Series BOct 2012$30.9M
Venture RoundSep 2010$16M
$46.9M